Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the national cancer institute's anticancer drug screen panel-Reference-Cited by-同舟云学术

Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the national cancer institute's anticancer drug screen panel

Published:1996-12 Issue:12 Volume:52 Page:1855-1865
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Rixe Olivier,Ortuzar Waldo,Alvarez Manuel,Parker Ricardo,Reed Eddie,Paull Ken,Fojo Tito

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference48 articles.

1. Fundamental studies with cisplatin;Rosenberg;Cancer,1985

2. Cancer of the testis;Einhorn,1993

3. Cancer of the ovary;Young,1993

4. Molecular basis of cisplatin resistance in human carcinomas: Model systems and patients;Scanlon;Anticancer Res,1989

5. Cisplatin and platinum analogues: Recent advances;Fram;Curr Opin Oncol,1992

Cited by 523 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What is the Reason That the Pharmacological Future of Chemotherapeutics in the Treatment of Lung Cancer Could Be Most Closely Related to Nanostructures? Platinum Drugs in Therapy of Non-Small and Small Cell Lung Cancer and Their Unexpected, Possible Interactions. The Review;International Journal of Nanomedicine;2024-09

2. An Outlook on Platinum-Based Active Ingredients for Dermatologic and Skincare Applications;Nanomaterials;2024-08-02

3. Discovery of the Next-Generation Platinum-Based Anticancer Agents for Combating Oxaliplatin-Induced Drug Resistance;Journal of Medicinal Chemistry;2024-06-07

4. The Unique Pt(II)-Induced Nucleolar Stress Response and its Deviation from DNA Damage Response Pathways;2024-06-07

5. Platinum(0)-η2-1,2-(E)ditosylethene Complexes Bearing Phosphine, Isocyanide and N-Heterocyclic Carbene Ligands: Synthesis and Cytotoxicity towards Ovarian and Breast Cancer Cells;Molecules;2024-03-01